AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting

– More than 20 abstracts, including one late-breaking presentation, underscore AbbVie’s dedication to advancing care for dermatologic conditions NORTH CHICAGO, Ill., March 13, 2023 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced it will present more than 20 abstracts, including one…

About the Author

has written 41558 stories on this site.

Copyright © 2010 Business and Corporate News.